Valuation: Consort Medical plc

Market Cap 502M 450M 411M 376M 708M 47.18B 730M 4.96B 1.98B 25.18B 1.88B 1.84B 79.48B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 538M 491M 448M 845M 56.34B 872M 5.92B 2.36B 30.06B 2.25B 2.2B 94.9B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 52 01/04/2024
Director/Board Member 46 01/02/2023
Director/Board Member 53 01/04/2024
Date Insider Type Main position Quantity % Market Cap. Importance
06/02/20 Sell 211,474 0.4284%
06/02/20 Exercice 211,474 0.4284%
06/02/20 Sell 467 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
-3.23%+3.51%-12.02%+15.72% 190B
-2.90%+5.45%+13.04%+38.65% 125B
-2.75%+11.65%-7.90%+17.71% 124B
+0.96%+5.15%-38.02%+12.24% 99.31B
-1.80%+0.82%-7.41%+69.42% 63.65B
-0.78%+7.07%+19.44%-18.22% 57.71B
+0.79%+22.65%-5.28%+59.81% 53.26B
-6.98%-14.56%-12.60%+42.69% 47.03B
-2.36%+3.72%+3.27%-8.07% 36.15B
Average -1.90%+4.79%-5.28%+25.55% 79.68B
Weighted average by Cap. -2.20%+5.70%-6.94%+24.48%

Financials

2018 2019
Net sales 311M 279M 255M 233M 439M 29.24B 452M 3.07B 1.23B 15.6B 1.17B 1.14B 49.26B 305M 274M 250M 228M 430M 28.68B 444M 3.01B 1.2B 15.3B 1.15B 1.12B 48.31B
Net income 16.1M 14.44M 13.2M 12.05M 22.7M 1.51B 23.41M 159M 63.43M 808M 60.43M 59.14M 2.55B 10.5M 9.42M 8.61M 7.86M 14.8M 987M 15.27M 104M 41.37M 527M 39.41M 38.57M 1.66B
Net Debt 95.5M 85.65M 78.28M 71.46M 135M 8.98B 139M 944M 376M 4.79B 358M 351M 15.12B 97.4M 87.36M 79.84M 72.88M 137M 9.16B 142M 962M 384M 4.89B 366M 358M 15.42B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock